Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 837 | 971 | 858 | - | - | - |
| Fund Return | -16.26% | -2.92% | -14.24% | - | - | - |
| Place in category | - | - | - | - | - | - |
| % in Category | - | - | - | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Tebon Xinxing Value mix A | 8.98B | 128.90 | 48.10 | 15.94 | ||
| Tebon Xinxing Value mix C | 8.98B | 128.69 | 47.96 | 15.63 | ||
| Tebon Selected Alloc | 194.77M | 1.06 | -3.33 | 2.66 | ||
| Tebon Big Health Flxbl Alloc Fd | 151.59M | 7.95 | -8.48 | 4.86 | ||
| Tebon Fuxin Flxble Alloc A | 99.08M | 37.91 | 0.22 | 6.39 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Tebon Xinxing Value mix C | 8.98B | 128.69 | 47.96 | 15.63 | ||
| Tebon Xinxing Value mix A | 8.98B | 128.90 | 48.10 | 15.94 | ||
| IGW Stable Return Flexible Fd A | 6.06B | 131.91 | 46.98 | 16.19 | ||
| IGW Stable Return Flexible Fd C | 6.06B | 131.39 | 46.60 | 15.88 | ||
| China Universal DX Alloc C | 2.55B | 42.35 | 11.97 | 9.31 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| O-Film Tech A | CNE100000S33 | 7.59 | 11.00 | -0.63% | |
| Northeast Phar A | CNE0000009G0 | 4.60 | 5.26 | -1.50% | |
| Hubei Jumpcan Pharm | CNE0000018X6 | 4.36 | 26.28 | -0.90% | |
| New Beiyang It A | CNE100000M62 | 4.19 | 7.82 | -0.38% | |
| Kelun Pharm A | CNE100000PW7 | 4.06 | 32.02 | -2.08% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | BUY |
| Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review